Cytrix: Driving Organoid Research Forward
Cytrix provides a comprehensive portfolio of organoid products designed to advance both basic and translational research. Our 3D-ready organoid models, derived from healthy tissue, Induced Pluripotent Stem Cells (iPSCs), patient samples, and selected animal sources, covering a wide range of organs including liver, lung, brain, colon, pancreas, and breast. These models recapitulate key aspects of native tissue architecture, maintain key genomic features over passages under defined conditions, and patient-derived models retain disease-relevant phenotype, making them powerful systems for studying human development, disease mechanisms, drug response, and precision medicine applications.
To support reliable organoid establishment and long-term growth, we supply a full range of media and reagents, including culture media, basement membranes matrix, growth factors, and culture plates, all support robust expansion and controlled differentiation. Complementing these are organoid-validated antibodies targeting key lineage, immune, and tumor-associated markers, rigorously validated across applications such as IHC, IF, WB, and flow cytometry to provide high-confidence results.
Beyond models and reagents, Cytrix also delivers a range of services that broaden the possibilities of organoid research. All our products and services are supported by stringent quality control measures to ensure consistency, reliability, and scientific rigor across every stage of research.
With a portfolio that unites organoid models, culture systems, antibodies, and advanced services, Cytrix equips researchers with the tools and confidence to generate reproducible, clinically relevant insights and to accelerate the journey from discovery to therapeutic innovation.
Product Features
-
Diverse Origins
Organoid models derived from ASCs, iPSCs, or tissues, including both healthy and disease-specific samples.
-
Physiological Relevance
Organoids maintain native tissue architecture and functional properties that closely mimic in vivo conditions.
-
Long-Term Stability
Demonstrated genetic and phenotypic stability across extended culture periods, ensuring reproducibility.
Showing 307–315 of 387 results
Recombinant Human FGF-7 Protein, Premium Grade, Tag-Free
Molecular Weight19.0 kDa
EndotoxinLess than 0.01 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Human FGF-7 Protein, His Tag
Molecular Weight20.9 kDa
EndotoxinLess than 0.01 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Human FGF-7 Protein, His Tag ,Avi Tag,Biotinylated
Molecular Weight22.6 kDa
Expression SystemHuman 293 cells (HEK293)
Recombinant Human Transforming growth factor-alpha/TGF-alpha Protein
Molecular Weight5.7 kDa
EndotoxinLess than 0.01 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Human BMP-2 Protein, Premium Grade, Tag-Free
Molecular Weight12.8 kDa
EndotoxinLess than 0.2 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Human FGF-10 Protein, His Tag ,Avi Tag, Biotinylated
Molecular Weight22.9 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Human TGF-Beta 1 Protein, GMP
Molecular Weight12.8 kDa
EndotoxinLess than 0.01 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Human TGF-Beta 1 Protein, Tag-Free
Molecular Weight12.8 kDa
EndotoxinLess than 0.01 EU per μg by the LAL method / rFC method.
Expression SystemHuman 293 cells (HEK293)
Recombinant Mouse/Rat TGF-Beta 1 Protein, Avi Tag, Biotinylated
Molecular Weight14.7 kDa
Endotoxin/
Expression SystemHuman 293 cells (HEK293)
No matching products.
Whether you're exploring disease mechanisms or screening novel therapeutics, Cytrix is your trusted partner.
Let's build the future of gut research together.
